These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31642260)

  • 21. Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1.
    Shi J; Cao J; Lu X; Fan L; Guo H; Fu J
    Med Sci Monit; 2021 Apr; 27():e929199. PubMed ID: 33872295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
    Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
    J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Mutational and Transcriptional Landscapes of Speckle-Type POZ Protein (SPOP) and Androgen Receptor (AR) in a Single-Center pT3 Prostatectomy Cohort.
    Eryilmaz IE; Vuruskan BA; Kaygisiz O; Cecener G; Egeli U; Vuruskan H
    J Environ Pathol Toxicol Oncol; 2024; 43(1):15-29. PubMed ID: 37824367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.
    Shi Q; Zhu Y; Ma J; Chang K; Ding D; Bai Y; Gao K; Zhang P; Mo R; Feng K; Zhao X; Zhang L; Sun H; Jiao D; Chen Y; Sun Y; Zhao SM; Huang H; Li Y; Ren S; Wang C
    Mol Cancer; 2019 Nov; 18(1):170. PubMed ID: 31771591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer.
    Bernasocchi T; El Tekle G; Bolis M; Mutti A; Vallerga A; Brandt LP; Spriano F; Svinkina T; Zoma M; Ceserani V; Rinaldi A; Janouskova H; Bossi D; Cavalli M; Mosole S; Geiger R; Dong Z; Yang CG; Albino D; Rinaldi A; Schraml P; Linder S; Carbone GM; Alimonti A; Bertoni F; Moch H; Carr SA; Zwart W; Kruithof-de Julio M; Rubin MA; Udeshi ND; Theurillat JP
    Nat Commun; 2021 Feb; 12(1):734. PubMed ID: 33531470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
    Blattner M; Liu D; Robinson BD; Huang D; Poliakov A; Gao D; Nataraj S; Deonarine LD; Augello MA; Sailer V; Ponnala L; Ittmann M; Chinnaiyan AM; Sboner A; Chen Y; Rubin MA; Barbieri CE
    Cancer Cell; 2017 Mar; 31(3):436-451. PubMed ID: 28292441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulation of SPOP in Cancer.
    Zhang H; Jin X; Huang H
    Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis.
    Ding G; Sun J; Jiang L; Gao P; Zhou Q; Wang J; Tong S
    Open Med (Wars); 2020; 15(1):1039-1047. PubMed ID: 33336059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex.
    Watanabe R; Maekawa M; Hieda M; Taguchi T; Miura N; Kikugawa T; Saika T; Higashiyama S
    Mol Biol Cell; 2020 Mar; 31(6):478-490. PubMed ID: 31967940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.
    Huang Y; Tan N; Jia D; Jing Y; Wang Q; Li Z; Zhang J; Liu L; Li J; Chen Z; He X
    Tumour Biol; 2015 Dec; 36(12):9753-61. PubMed ID: 26156804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications.
    Yang X; Zhu Q
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Snail promotes prostate cancer migration by facilitating SPOP ubiquitination and degradation.
    Lv W; Huan M; Yang W; Gao Y; Wang K; Xu S; Zhang M; Ma J; Wang X; Chen Y; Li L
    Biochem Biophys Res Commun; 2020 Aug; 529(3):799-804. PubMed ID: 32736710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPOP promotes transcriptional expression of DNA repair and replication factors to prevent replication stress and genomic instability.
    Hjorth-Jensen K; Maya-Mendoza A; Dalgaard N; Sigurðsson JO; Bartek J; Iglesias-Gato D; Olsen JV; Flores-Morales A
    Nucleic Acids Res; 2018 Oct; 46(18):9484-9495. PubMed ID: 30124983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
    Lehrer S; Rheinstein PH
    Cancer Genomics Proteomics; 2020; 17(3):271-275. PubMed ID: 32345668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrated quantitative proteomic and metabolomics approach to reveal the negative regulation mechanism of LamB in antibiotics resistance.
    Li W; Wang G; Zhang S; Fu Y; Jiang Y; Yang X; Lin X
    J Proteomics; 2019 Mar; 194():148-159. PubMed ID: 30521976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation.
    Lai J; Batra J
    Asian J Androl; 2014; 16(5):659-60. PubMed ID: 24969063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer.
    Zhi X; Tao J; Zhang L; Tao R; Ma L; Qin J
    Cell Death Dis; 2016 Dec; 7(12):e2569. PubMed ID: 28032859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.
    Lee CJ; Lee H; Kim SR; Nam SB; Lee GE; Yang KE; Lee GJ; Chun SH; Kang HC; Lee JY; Lee HS; Cho SJ; Cho YY
    Cell Death Dis; 2024 Apr; 15(4):274. PubMed ID: 38632244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis.
    Ma J; Cai M; Mo Y; Fried JS; Tan X; Ma Y; Chen J; Han S; Xu B
    Front Oncol; 2021; 11():658230. PubMed ID: 34322378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments.
    Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T
    Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.